about
Molecular evidence of sexual transmission of Ebola virusMonitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in LiberiaBacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevanceDetection of bluetongue virus antigens in Culicoides variipennis by enzyme immunoassayDetection of bluetongue virus serotype 17 in Culicoides variipennis by nucleic acid blot and sandwich hybridization techniquesDetection of dengue virus serotypes 1, 2 and 3 in selected regions of Kenya: 2011–2014Evolution and Spread of Ebola Virus in Liberia, 2014-2015Circulating microRNA profiles of Ebola virus infectionDepartment of Defense influenza and other respiratory disease surveillance during the 2009 pandemic.Undiagnosed acute viral febrile illnesses, Sierra Leone.Isolation and characterisation of Ebolavirus-specific recombinant antibody fragments from murine and shark immune libraries.Development and evaluation of a panel of filovirus sequence capture probes for pathogen detection by next-generation sequencing.Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjectsPossible sexual transmission of Ebola virus - Liberia, 2015.Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014.Seroprevalance of Crimean-Congo haemorrhagic fever in Bulgarian livestockCapacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case reportCrimean-Congo hemorrhagic fever, Afghanistan, 2009Rapid discovery and optimization of therapeutic antibodies against emerging infectious diseases.Directed mutagenesis of a Sindbis virus pathogenesis site.Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain sheddingDetection of viral RNA from paraffin-embedded tissues after prolonged formalin fixation.Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study.Draft Genome Sequences of Eight Crimean-Congo Hemorrhagic Fever Virus Strains.Corning HYPERFlask® for viral amplification and production of diagnostic reagents.Comparison of MagPix Assays and Enzyme-Linked Immunosorbent Assay for Detection of Hemorrhagic Fever Viruses.Lateral Flow Immunoassays for Ebola Virus Disease Detection in Liberia.Evaluation of ViroCyt® Virus Counter for rapid filovirus quantitation.Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses.Infection of Aedes albopictus and Aedes aegypti mosquitoes with dengue parent and progeny candidate vaccine viruses: a possible marker of human attenuation.Dengue 3 virus infection of Aedes albopictus and Aedes aegypti: comparison of parent and progeny candidate vaccine viruses.Growth and stability of a cholesterol-independent Semliki Forest virus mutant in mosquitoes.Effects of La Crosse virus infection on pregnant domestic rabbits and mongolian gerbils.Comparison of Transcriptomic Platforms for Analysis of Whole Blood from Ebola-Infected Cynomolgus Macaques.Virus-encoded miRNAs in Ebola virus disease.Crimean-Congo Hemorrhagic Fever Virus, Mongolia, 2013-2014Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosisFDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science
P50
Q23922091-D9A7D7BA-3A94-4C7E-B7A2-E62191FE0CFFQ24696012-00AD00AD-BBD3-47CE-A52C-8C9B32F6C4B1Q27486385-820CE8BE-6494-451D-A328-679DA6A8B41DQ27488352-3DE0199F-B90A-4D34-9024-E83ADC24AE71Q27488379-EB284D70-42D2-4E54-863C-7C011D2FEBD6Q27926248-BA42FBBE-4B67-4656-B540-2DFC226F1861Q28383959-9C0E3169-755D-4331-AE5D-022D377D23B3Q28392668-C8AAF9EC-FE04-499F-A676-8B32F915933AQ30400578-709E7721-EB76-4DE8-AB5D-68D8DEE2E448Q33816394-75388EA3-EAEE-4657-8C63-4368F0E307E9Q33959980-AD573813-FE95-4918-885C-9F4CFF26D8D9Q34160194-62E0CA89-3EA9-45FD-831D-43FEF0F32F8EQ34322342-AE2CC1EC-9EF8-4316-891B-0ED4F2886661Q34360611-F729D3B8-AFFA-4190-9FBC-4B082DD37FAAQ34475415-0B4E9C87-3F2E-45C7-A957-A56C8377775BQ34580917-B932622F-85AB-410C-8E84-71CE68D1B677Q35614013-79F7D0BC-A333-4E4E-ADE0-ADE384050C58Q35770348-37BAFB5E-959C-45CB-819E-564BE75C2116Q35847584-FA9C2099-4CA2-4E5C-835E-202731347575Q36763346-69754F24-D55B-4681-A967-60ABCFEEC917Q36777364-A263F58D-6610-418E-8A51-234AA2F6CB37Q37103833-5FA028B5-BDAA-45A1-A16F-D2D738DE4126Q38498120-984A5353-3B74-415C-AE62-20804511A91AQ38859287-B2672447-DDF5-4D87-8244-46766DB8E20BQ40053338-119C423A-2125-408B-945F-3AA8BDADE5EAQ40075315-54D90E07-B249-4345-BF19-A88C5ADC53D3Q40082353-DE0FBEA9-A96E-4ADA-8662-4476C3E5EB52Q40095646-42906E2D-EC13-462A-AA05-6CFF55B929ABQ40168081-271D6791-2253-4972-A7AB-5BFF3E4272EEQ40254663-1EBB094D-D56C-4DB7-9E8F-6CF64CA8E47CQ40746055-6132A7AE-4BB4-4487-819D-EB367895FAC8Q40766589-859D7972-8A2A-44FD-877C-909B2EE2B84CQ40926176-D4E45F8D-305F-4984-9932-E16BA706D0FAQ42980139-15F16D8A-BC11-4DD7-94C0-E0FBE509EF97Q44106105-7D08CA69-AD94-4DAE-B43F-B9A479F43594Q55312013-3CA8B531-9635-4B5A-875B-5CD1758D58DAQ59350506-418674EB-35AC-4806-8F87-54174359EC9EQ90306747-8061C4E8-CAE8-47D3-834B-706CE088EC42Q92185997-29BD038D-B021-4ACE-9999-9031A5ED4E63
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Randal J Schoepp
@ast
Randal J Schoepp
@en
Randal J Schoepp
@es
Randal J Schoepp
@nl
type
label
Randal J Schoepp
@ast
Randal J Schoepp
@en
Randal J Schoepp
@es
Randal J Schoepp
@nl
prefLabel
Randal J Schoepp
@ast
Randal J Schoepp
@en
Randal J Schoepp
@es
Randal J Schoepp
@nl
P106
P1153
6601979443
P21
P31
P496
0000-0002-5026-0404